Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000800326 | SCV000940034 | pathogenic | Nemaline myopathy 2 | 2018-08-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln7911*) in the NEB gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs537560378, ExAC 0.006%). This variant has not been reported in the literature in individuals with NEB-related disease. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). For these reasons, this variant has been classified as Pathogenic. |